Abstract:Spinocerebellar ataxia type 7 (SCA7) is a rare autosomal dominant neurodegenerative disorder characterized by progressive neuronal loss in the cerebellum, brainstem, and retina, leading to cerebellar ataxia and blindness as major symptoms. SCA7 is due to the expansion of a CAG triplet repeat that is translated into a polyglutamine tract in ATXN7. Larger SCA7 expansions are associated with earlier onset of symptoms and more severe and rapid disease progression. Here, we summarize the pathological and genetic aspects of SCA7, compile the current knowledge about ATXN7 functions, and then focus on recent advances in understanding the pathogenesis and in developing biomarkers and therapeutic strategies. ATXN7 is a bona fide subunit of the multiprotein SAGA complex, a transcriptional coactivator harboring chromatin remodeling activities, and plays a role in the differentiation of photoreceptors and Purkinje neurons, two highly vulnerable neuronal cell types in SCA7. Polyglutamine expansion in ATXN7 causes its misfolding and intranuclear accumulation, leading to changes in interactions with native partners and/or partners sequestration in insoluble nuclear inclusions. Studies of cellular and animal models of SCA7 have been crucial to unveil pathomechanistic aspects of the disease, including gene deregulation, mitochondrial and metabolic dysfunctions, cell and non-cell autonomous protein toxicity, loss of neuronal identity, and cell death mechanisms. However, a better understanding of the principal molecular mechanisms by which mutant ATXN7 elicits neurotoxicity, and how interconnected pathogenic cascades lead to neurodegeneration is needed for the development of effective therapies. At present, therapeutic strategies using nucleic acid-based molecules to silence mutant ATXN7 gene expression are under development for SCA7.

Clinical Features and Mutation Analysis on Spinocerebellar Ataxia 7

The Clinical Features and Gene Mutation Analysis in a Pedigree of Spinocerebellar Ataxia Type 7

Research on gene mutation and clinical characteristics of hereditary spinocerebellar ataxia type 6 from 2 Chinese families

Clinical Characteristics and Gene Mutation Analysis of Hereditary Spinocerebellar Ataxia Type 7: a Study of 2 Chinese Families

Clinical Characteristics and Molecular Biology of Hereditary Spinocerebellar Ataxia Type 7: Study of 3 Chinese Families

Clinical and mutation analysis of hereditary spinocerebellar ataxia type 7 from a Chinese predigree

Clinical Characteristics and Genetic Diagnosis of Hereditary Spinocerebellar Ataxia Type 7

Clinical and Genetic Study of a Chinese Family with Spinocerebellar Ataxia Type 7.

[Frequency Analysis of Autosomal Dominant Spinocerebellar Ataxias in Han Population in the Chinese Mainland and Clinical and Molecular Characterization of Spinocerebellar Ataxia Type 6].

[Genetic and Clinical Analysis in a Parkinson's Disease Family Caused by Expansion of SCA2].

Spinocerebellar Ataxia Type 10 in Chinese Han

Clinical and molecular analyses of a Chinese spinocerebellar ataxia type 7 family that includes infantile-onset cases

Spinocerebellar Ataxia Type 6 in Mainland China: Molecular and Clinical Features in Four Families.

Genetic and Clinical Analyses of Spinocerebellar Ataxia Type 8 in Mainland China

Clinical Characteristics, Radiological Features and Gene Mutation in 10 Chinese Families with Spinocerebellar Ataxias

Molecular Genetics of a Chinese Family with Spinocerebellar Ataxia

The clinical study on hereditary spinocerebellar ataxia 7

Clinical Feature and Molecular Genetics of Hereditary Spinocerebellar Ataxia:Study of 41 Patients

Chinese abnormal compound heterozygote spinocerebellar ataxia type 8: a case report

Gene mutation and clinical feature of 10 patients with spinocerebellar ataxia type 2 and type 3

Molecular Targets and Therapeutic Strategies in Spinocerebellar Ataxia Type 7